CurifyLabs

CurifyLabsCurifyLabs
CurifyLabs

CurifyLabs

Automating pharmaceutical compounding for personalized medicine.

DR 402021ActiveHelsinki, Finland
Rate

About

CurifyLabs offers a connected compounding platform that automates non-sterile pharmaceutical compounding for pharmacies. Their solution integrates validated excipient bases, automated hardware, real-time quality control, and digital documentation to deliver personalized, patient-specific treatments faster and more consistently. This system is designed to serve pharmacies looking to future-proof their compounding processes and provide better outcomes for patients requiring personalized medicine.
Frequently asked

What does CurifyLabs do?

CurifyLabs offers a connected compounding platform that automates non-sterile pharmaceutical compounding for pharmacies. Their solution integrates validated excipient bases, automated hardware, real-time quality control, and digital documentation to deliver personalized, patient-specific treatments faster and more consistently. This system is designed to serve pharmacies looking to future-proof their compounding processes and provide better outcomes for patients requiring personalized medicine.

What is CurifyLabs's revenue?

StartupHub estimates CurifyLabs's annual revenue at $1.9M (range $1.0M to $8.4M, 30% confidence), based on comparable companies in the sector.

What is CurifyLabs's valuation?

StartupHub estimates CurifyLabs's effective valuation at $45.8M (range $30.0M to $72.0M, 23% confidence), based on comparable companies in the sector.

How much funding has CurifyLabs raised?

CurifyLabs has raised a total of $12M in funding. The most recent round on record is Series A.

Where is CurifyLabs headquartered?

CurifyLabs is headquartered in Helsinki, Finland.

When was CurifyLabs founded?

CurifyLabs was founded in 2021.

What industry does CurifyLabs operate in?

CurifyLabs operates in HealthTech, Biotechnology, Pharmaceuticals, Manufacturing Technology, 3D Printing, MedTech.

Comments

No comments yet. Be the first to share your take.